← Back
$MLYS All transactions

Mineralys Therapeutics, Inc.

▼ SELL

$ Value

$463K

Shares

10,115

Price

$46

Filed

Nov 13

Insider

Name

Karydas Daphne

Title

CIK

0001816952

Roles

Director

Transaction Details

Transaction Date

2025-11-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,885

Footnotes

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.19 to $46.18. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.19 to $46.70. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. | The stock option vests in 12 monthly installments following the date of grant.

Filing Info

Accession No.

0001933414-25-000150

Form Type

4

Issuer CIK

0001933414

Karydas Daphne's History

Date Ticker Type Value
2026-03-31 MLYS M $36K
2026-03-31 MLYS $75K
2026-03-31 MLYS M $0
2025-11-13 MLYS M $153K
2025-11-13 MLYS $463K
2025-11-13 MLYS $226K
2025-11-13 MLYS M $0
2025-06-12 CMPS A $0

Other Insiders at MLYS (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. $8.8M 2026-03-30
Congleton Jon
Chief Executive Officer
$2.4M 2026-04-13
Rodman David Malcom
Chief Medical Officer
$621K 2026-04-17
Karydas Daphne $75K 2026-03-31